Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd Ordinary Shares BMGL Peers
See (BMGL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BMGL | $2.25 | -24.24% | 42.3M | 225.00 | $0.01 | N/A |
| UNH | $304.10 | +1.53% | 275.7B | 12.73 | $23.88 | +3.51% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +2.45% |
| CVS | $64.78 | -1.28% | 81.9B | 15.46 | $4.19 | +4.11% |
| CI | $303.27 | -1.78% | 81B | 16.91 | $17.93 | +2.38% |
| ELV | $340.67 | -1.50% | 76.9B | 13.25 | $25.71 | +2.45% |
| HUM | $230.67 | -0.65% | 27.8B | 16.29 | $14.16 | +1.92% |
| CNC | $31.44 | -3.32% | 15.6B | 4.63 | $6.78 | N/A |
| MOH | $221.55 | -3.08% | 12B | 10.69 | $20.71 | N/A |
| OSCR | $14.38 | -7.41% | 3.7B | 35.95 | $0.40 | N/A |
Stock Comparison
BMGL vs UNH Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, UNH has a market cap of 275.7B. Regarding current trading prices, BMGL is priced at $2.25, while UNH trades at $304.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas UNH's P/E ratio is 12.73. In terms of profitability, BMGL's ROE is +0.32%, compared to UNH's ROE of +0.24%. Regarding short-term risk, BMGL is more volatile compared to UNH. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ANTM Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, BMGL is priced at $2.25, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas ANTM's P/E ratio is 18.99. In terms of profitability, BMGL's ROE is +0.32%, compared to ANTM's ROE of +0.14%. Regarding short-term risk, BMGL is more volatile compared to ANTM. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CVS Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, CVS has a market cap of 81.9B. Regarding current trading prices, BMGL is priced at $2.25, while CVS trades at $64.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas CVS's P/E ratio is 15.46. In terms of profitability, BMGL's ROE is +0.32%, compared to CVS's ROE of +0.07%. Regarding short-term risk, BMGL is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CI Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, CI has a market cap of 81B. Regarding current trading prices, BMGL is priced at $2.25, while CI trades at $303.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas CI's P/E ratio is 16.91. In terms of profitability, BMGL's ROE is +0.32%, compared to CI's ROE of +0.12%. Regarding short-term risk, BMGL is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ELV Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, ELV has a market cap of 76.9B. Regarding current trading prices, BMGL is priced at $2.25, while ELV trades at $340.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas ELV's P/E ratio is 13.25. In terms of profitability, BMGL's ROE is +0.32%, compared to ELV's ROE of +0.14%. Regarding short-term risk, BMGL is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs HUM Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, HUM has a market cap of 27.8B. Regarding current trading prices, BMGL is priced at $2.25, while HUM trades at $230.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas HUM's P/E ratio is 16.29. In terms of profitability, BMGL's ROE is +0.32%, compared to HUM's ROE of +0.10%. Regarding short-term risk, BMGL is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CNC Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, CNC has a market cap of 15.6B. Regarding current trading prices, BMGL is priced at $2.25, while CNC trades at $31.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas CNC's P/E ratio is 4.63. In terms of profitability, BMGL's ROE is +0.32%, compared to CNC's ROE of +0.13%. Regarding short-term risk, BMGL is more volatile compared to CNC. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MOH Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, MOH has a market cap of 12B. Regarding current trading prices, BMGL is priced at $2.25, while MOH trades at $221.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas MOH's P/E ratio is 10.69. In terms of profitability, BMGL's ROE is +0.32%, compared to MOH's ROE of +0.26%. Regarding short-term risk, BMGL is more volatile compared to MOH. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs OSCR Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, OSCR has a market cap of 3.7B. Regarding current trading prices, BMGL is priced at $2.25, while OSCR trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas OSCR's P/E ratio is 35.95. In terms of profitability, BMGL's ROE is +0.32%, compared to OSCR's ROE of +0.11%. Regarding short-term risk, BMGL is more volatile compared to OSCR. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ALHC Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, ALHC has a market cap of 2.6B. Regarding current trading prices, BMGL is priced at $2.25, while ALHC trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas ALHC's P/E ratio is -28.48. In terms of profitability, BMGL's ROE is +0.32%, compared to ALHC's ROE of -0.81%. Regarding short-term risk, BMGL is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CLOV Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, CLOV has a market cap of 1.5B. Regarding current trading prices, BMGL is priced at $2.25, while CLOV trades at $2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas CLOV's P/E ratio is -73.12. In terms of profitability, BMGL's ROE is +0.32%, compared to CLOV's ROE of -0.07%. Regarding short-term risk, BMGL is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs BHG Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, BMGL is priced at $2.25, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas BHG's P/E ratio is -0.12. In terms of profitability, BMGL's ROE is +0.32%, compared to BHG's ROE of -0.47%. Regarding short-term risk, BMGL is more volatile compared to BHG. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MRAI Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, MRAI has a market cap of 18.6M. Regarding current trading prices, BMGL is priced at $2.25, while MRAI trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas MRAI's P/E ratio is -0.43. In terms of profitability, BMGL's ROE is +0.32%, compared to MRAI's ROE of +0.75%. Regarding short-term risk, BMGL is more volatile compared to MRAI. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs NIVF Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, NIVF has a market cap of 2.7M. Regarding current trading prices, BMGL is priced at $2.25, while NIVF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas NIVF's P/E ratio is N/A. In terms of profitability, BMGL's ROE is +0.32%, compared to NIVF's ROE of +0.03%. Regarding short-term risk, BMGL is more volatile compared to NIVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs IVF Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, IVF has a market cap of 1.7M. Regarding current trading prices, BMGL is priced at $2.25, while IVF trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas IVF's P/E ratio is -0.02. In terms of profitability, BMGL's ROE is +0.32%, compared to IVF's ROE of -5.72%. Regarding short-term risk, BMGL is more volatile compared to IVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs GTS Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, GTS has a market cap of 0. Regarding current trading prices, BMGL is priced at $2.25, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas GTS's P/E ratio is 10.41. In terms of profitability, BMGL's ROE is +0.32%, compared to GTS's ROE of +0.07%. Regarding short-term risk, BMGL is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MGLN Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 42.3M. In comparison, MGLN has a market cap of 0. Regarding current trading prices, BMGL is priced at $2.25, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 225.00, whereas MGLN's P/E ratio is 8.49. In terms of profitability, BMGL's ROE is +0.32%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, BMGL is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.